2026-10-04
FST clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
NAS100 27,087 +1.72%
S&P 7,401 +0.65%
GOLD $4,073 −1.00%
BTC $75,828 −0.15%
VIX 24.55 −12.88%
latest tape · as of 20:03 UTC
The Screen · Consumer Cyclical · Leisure
FST Corp
KBSX · NASDAQ · USD · Market cap $38M · 382 employees
FST Corp.
Not yet scored1.37 USD
Price as of 5 Nov 2026Daily close, not a live quote
Screened 2026-11-05 · the tape above runs as of 20:03 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price1.37 USD at the 5 Nov 2026 close
- Fair valueUnder review: our model's value is 2.13x the price, above our 2.00x limit.
- Our regime readDistribution, as of 5 Nov 2026
- Ethical screenNot yet scored
- Last reviewed5 Nov 2026 (1 days ago)
- Release timesRelease and earnings times on your chart: Event Guard Mentor
A summary of the dated readings below, not a live quote and not advice.
PRICE · ONE YEAR
Our fair-value range: range not available (screen dated 2026-11-05).
- Trend Distribution
- Insiders no filings inside 60 days, left as found
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical screen not yet scored
Price1.37 USD
Fair valueUnder review
Ethical score70.0/100
Our investment reviews on this name
2026-11-01Read Distribution1.37+0.0% to today Markup gives way to Distribution after a 59% rise in 8 weeks
2026-09-03Read Markup0.86+59.3% to today ✓Distribution gives way to Markup first Markup read since July
2026-08-03Read Distribution0.86+59.3% to today Markup gives way to Distribution after a 34% slide in 5 weeks
2026-07-02Read Markup1.31+4.6% to today ✓First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its distribution label.
FST Corp holds its Distribution at $1.37. The statistical read favours the sellers, held for 75 days.
| Phase | Distribution · caution |
| Quantitative state | The statistical read favours the sellers, held for 75 days |
| Price at the screen | $1.37 |
| Valuation | 15.29 trailing · 9.73 forward price to earnings |
| Values screen | Not scored · score 70.0 |
| Beta | 0.36 |
Five Screens, Shown in Full
This security has not been fully scored against the values screen yet.
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadThe Read, in Plain English
FST clears the business-activity screen and the figures we can measure look clean, but one or more financial figures are still pending, so the verdict is not final yet.
Read as at 2026-11-05. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
We do not yet have the financial statements needed to run the debt, cash, receivables and income screens for FST, so it is not scored yet.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
What the Numbers Say It Is WorthThe Fair Value Range
Fair value under review. Our model's value is 2.13x the price, above our 2.00x limit. We show no fair value, margin of safety or value read built on it until the review clears.
How a fair value is estimated: discounted cash flow (DCF).
The Street's RangeThird-party analyst targets. The average target sits +155% from the screen price.
Where our models see it going: no fair-value estimate yet, range not available, dated to the 2026-11-05 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | 9.7xcheap for a company growing this fast |
| Trailing P/E | 15.3xreasonably valued |
| EPS, trailing | 0.07 |
| EPS, forward | 0.11 |
| Revenue growth | +36.2%strong top-line growth |
| Profit margin | 6.1%thin but positive margins |
| Return on equity | 15.8%a solid return on shareholder capital |
| FCF yield | 1.46% |
| Debt to equity | 2.07heavy leverage: higher risk if revenue softens |
| Current ratio | 0.96below 1: short-term bills exceed liquid assets |
| Beta | 0.36barely tracks the market's swings |
| Short interest, float | 0.01% |
| 52-week range | 0.81 - 1.83 |
| Moat | NONE |
| Market cap | $38M |
| Employees | 382 |
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; its business and earnings are exposed to Taiwan and to currency swings; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeKBSX trades on NASDAQ (the company is based in Taiwan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-11-01
Distribution · changed $1.37
-2.5% Entry 8
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.5% since our last review. Ethical screening: not fully scored yet. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $4.
2026-10-19
Markup $1.40
+31.3% Entry 7
The analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 31.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $4.
2026-10-02
Markup $1.07
+24.4% Entry 6
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 24.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $4.
2026-09-03
Markup · changed $0.86
+0.0% Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $4.
2026-08-03
Distribution · changed $0.86
-34.4% Entry 4
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 34.4% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $4.
2026-07-18
Markup $1.31
+0.0% Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 13%. Our forward projection puts the odds of a 10% gain over the next month near 24%. The street (2 analysts) rates it none, with a mean price target of $4.
2026-07-03
Markup $1.31
+0.0% Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
2026-07-02
Markup $1.31
Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
NOMANomadar Corp
GDHGGolden Heaven Group Holdings Ltd
KMRKK-Tech Solutions Company Ltd
PUSAAureus Greenway Holdings Inc
HEREHere Group Ltd ADR
DOGZDogness (International) Corp
Screened names in the same industry · explore each on its own page.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $1.34 | +0.7% | · | $1,007 | +0.7% |
| 2 months | $1.33 | +1.5% | · | $1,015 | +1.5% |
| 3 months | $1.31 | +3.1% | · | $1,031 | +3.1% |
| 6 months | $1.49 | -9.4% | · | $906 | -9.4% |
| 1 year | $1.56 | -13.5% | · | $865 | -13.5% |
| 2 years | $11.35 | -88.1% | · | $119 | -88.1% |
| 3 years | $10.70 | -87.4% | · | $126 | -87.4% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever KBSX does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.